Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT02339805
Eligibility Criteria:
Inclusion Criteria:
* Age up to 18 years old
* With a diagnosis formally established of DLBCL or transformed straightaway follicular lymphoma or 3B grade follicular lymphoma or Burkitt-like lymphoma
* Eligible to a treatment by immunochemotherapy like R-CHOP, R-ACVBP or R-CHOP like
* First line of treatment
* Being able to benefit from standard extension assessment ( Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and bone marrow biopsy with a bone marrow aspiration)
* Written informed consent
* Tumor biopsy used for diagnosis available
Exclusion Criteria:
* Patient who cannot receive polychemotherapy like R-CHOP, R-ACVBP, or R-CHOP like
* Patient who cannot benefit from standard extension assessment and follow-up by with Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET)
* Pregnant or breast-feeding woman
* Guardianship, curatorship
* Patient who cannot follow the medical procedures of the study for geographic, social, psychological,linguistic or physical reasons
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02339805
Study Brief:
Protocol Section:
NCT02339805